STOCK TITAN

Avadel Pharmaceuticals plc (AVDL) Revenue by Year

AVDL NASDAQ

Avadel Pharmaceuticals plc generated $169.1M in revenue in fiscal year 2024. This represents an increase of 504.8% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $248.5M in revenue. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Avadel Pharmaceuticals plc has filed alongside them.

FY2024 annual
Revenue $169.1M
YoY +504.8%
5Y CAGR +23.4%
10Y CAGR +27.4%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AVDL Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
Revenue$248.5M$169.1M+504.8%$28.0Mn/m$0n/m$0-100.0%$22.3M-62.3%$59.2M-42.7%$103.3M-40.4%$173.2M+15.3%$150.2M-13.2%$173.0M+1055.3%$15.0M+258.3%$4.2M-84.1%$26.3M-20.8%$33.2M-10.5%$37.1M

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

AVDL Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Revenue$77.5M+54.9%$68.1M+64.2%$52.5M+93.2%$50.4M$50.0M+613.2%$41.5M+2674.3%$27.2Mn/mN/A$7.0Mn/m$1.5Mn/m$0N/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Avadel Pharmaceuticals plc financials

Frequently Asked Questions

What was Avadel Pharmaceuticals plc's revenue in fiscal year 2024?

Avadel Pharmaceuticals plc generated $169.1M in revenue in fiscal year 2024.

How fast is Avadel Pharmaceuticals plc's revenue growing?

Avadel Pharmaceuticals plc (AVDL) revenue rose by 504.8% year over year, from $28.0M to $169.1M in fiscal year 2024.

What is Avadel Pharmaceuticals plc's revenue over the last twelve months?

Avadel Pharmaceuticals plc (AVDL) reported $248.5M in revenue over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Avadel Pharmaceuticals plc (AVDL) revenue went from $37.1M in fiscal year 2010 to $169.1M in fiscal year 2024.

Avadel Pharmaceuticals plc (AVDL) reported $77.5M in revenue in Q3 2025. This represents an increase of 54.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Avadel Pharmaceuticals plc (AVDL) reported on that line in every period on record.